During the past decade, Nash General Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nash General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nash General Hospital" are "HER2/Neu Positive" (2 trials), "Progesterone Receptor Positive" (2 trials), "Recurrent Breast Carcinoma" (2 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (2 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (2 trials). Many other conditions were trialed in "Nash General Hospital" in a lesser frequency.

Most popular intervention types in "Nash General Hospital" are "Other" (8 trials), "Drug" (7 trials), "Biological" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Paclitaxel" (4 trials), "Quality-of-Life Assessment" (4 trials), "Questionnaire Administration" (4 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nash General Hospital" are 7 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nash General Hospital". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Nash General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nash General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Nash General Hospital has several departments that took part in Clinical trials: "UNC Cancer Care at Nash" - 2 trials